Some studies showed that NAFLD patients carrying the PNPLA3 G/G genotype had lower plasma adiponectin levels compared to those with the PNPLA3 C/C genotype [32], whereas others did not [14]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.